Interestingly, the sole putative phosphorylation site for GSK3α/β overlaps with one of three putative sites for ERK1/2, suggesting a potential interplay between GSK3- and ERK-related pathways with normal HTT (Q17) and/or pathogenic (Q109) HTT and in HD. The gene discussed is MAPK3; the disease is Huntington disease.